Parkinson's Disease (PD) is nowadays considered as a complex clinical condition in which motor symptoms coexist with several non-motor symptoms. A growing body of literature has addressed non-motor symptoms in PD [1], that are progressively being recognized as a potential source of distress for patients and their families, even greater than that imposed by the well-known motor impairments [2][3][4].The aim of this special issue was to gather together studies providing new findings about a specific subset of non-motor symptoms in PD: cognitive, behavioural and psychological disturbances, that are likely those with the highest impact on patient's daily life [5,6]. Within this framework we collected papers addressing neuropsychological defects (particularly frontal dysfunctions and dysexecutive syndromes) and neuropsychiatric disorders (such as hallucinations, depression and apathy, compulsive behavior), and highlighting the possible relationships of these symptoms with pharmacological treatment, and, above all, with each other.In the present issue a review by Friedman et al.[7] addressed occurrence of psychosis and hallucinations in PD. Psychotic symptoms are common in drug treated PD patients: visual hallucinations (VH) have been reported to occur in about 30%, whereas delusions, typically paranoid in nature, occur in about 5%. These